JALSG AML201, C000000157: Phase III Randomized Study of Induction Therapy Comparing Daunorubicin With Idarubicin Followed By Consolidation Therapy Comparing High-Dose Cytarabine With Sequential Multiagent Chemotherapy in Patients With Previously Untreated De Novo Acute Myeloid Leu |
|
|
| Completed | 3 | 850 | Japan | daunorubicin - Generic mfg., idarubicin hydrochloride - Generic mfg., cytarabine - Generic mfg. | Japan Adult Leukemia Study Group, Ministry of Health, Labor and Welfare | Acute Myeloid Leukemia | | | | |
